Bristol-Myers Squibb

BMS reveals its post-Celgene takeover management team
BMS reveals its post-Celgene takeover management team
Pharmaforum
Bristol-Myers Squibb
Celgene
M&A
Flag link:
Eli Lilly, BMS among 77 drugmakers targeted in Chinese financial probe
Eli Lilly, BMS among 77 drugmakers targeted in Chinese financial probe
Fierce Pharma
China
Sanofi
Eli Lilly
Bristol-Myers Squibb
Flag link:
In a much-needed positive for BMS, Celgene gains FDA review for blockbuster hopeful
In a much-needed positive for BMS, Celgene gains FDA review for blockbuster hopeful
Fierce Biotech
Celgene
Bristol-Myers Squibb
Acceleron
luspatercept
MDS
beta thalassemia
Flag link:
Gilead C-suite shifts again with chief commercial officer appointment
Gilead C-suite shifts again with chief commercial officer appointment
Biopharma Dive
Gilead Sciences
Bristol-Myers Squibb
Flag link:
Bristol-Myers' Opdivo fails late-stage brain cancer trial
Bristol-Myers' Opdivo fails late-stage brain cancer trial
Yahoo/Reuters
Bristol-Myers Squibb
Opdivo
clinical trials
glioblastoma multiforme
Flag link:
Don't worry about our $19B bond issue, BMS says. With Celgene, we'll have the cash to pay it off
Don't worry about our $19B bond issue, BMS says. With Celgene, we'll have the cash to pay it off
Fierce Pharma
M&A
Bristol-Myers Squibb
Celgene
Flag link:
Bristol-Myers Squibb Posts Solid Q1 Results With the Celgene Acquisition Looming
Bristol-Myers Squibb Posts Solid Q1 Results With the Celgene Acquisition Looming
Motley Fool
earnings
Bristol-Myers Squibb
Celgene
M&A
Flag link:
BMS' head and neck cancer hopes take a hit with Opdivo-Yervoy trial flop
BMS' head and neck cancer hopes take a hit with Opdivo-Yervoy trial flop
Fierce Pharma
Bristol-Myers Squibb
head and neck cancer
Opdivo
Yervoy
Flag link:
Bayer, J&J's Xarelto scripts stagnate as discounts, competition pile up
Bayer, J&J's Xarelto scripts stagnate as discounts, competition pile up
Fierce Pharma
Bayer
JNJ
Xarelto
bloodthinners
Bristol-Myers Squibb
Pfizer
Eliquis
Flag link:
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Yahoo/Benzinga
Concert Pharmaceuticals
Horizon Pharma
Edwards Lifesciences
Zimmer Biomet
Genfit
Precision Biosciences
Boston Scientific
AbbVie
Alexion
Bristol-Myers Squibb
Baxter
Biomarin
AtriCure
Biogen
Seattle Genetics
IPOs
earnings
Flag link:
Bristol-Myers Squibb (BMY) Reports Next Week: Wall Street Expects Earnings Growth
Bristol-Myers Squibb (BMY) Reports Next Week: Wall Street Expects Earnings Growth
Yahoo/Zacks.com
Bristol-Myers Squibb
earnings
Flag link:
Bristol-Myers CEO: We’re ‘one step closer to creating that great company’ with Celgene
Bristol-Myers CEO: We’re ‘one step closer to creating that great company’ with Celgene
CNBC
M&A
Bristol-Myers Squibb
Celgene
Pharma CEOs
Giovanni Caforio
Flag link:
The Bristol-Celgene merger is approved. Here are 8 challenges ahead
The Bristol-Celgene merger is approved. Here are 8 challenges ahead
Stat
Bristol-Myers Squibb
Celgene
M&A
Flag link:
Nobel laureate behind Bristol's I-O superstar Opdivo demands a bigger cut
Nobel laureate behind Bristol's I-O superstar Opdivo demands a bigger cut
Fierce Pharma
Opdivo
Bristol-Myers Squibb
Ono Pharmaceutical
R&D
Flag link:
Bristol-Myers details its failure on Checkmate 451, highlighting a bleak future for their checkpoint combo
Bristol-Myers details its failure on Checkmate 451, highlighting a bleak future for their checkpoint combo
Endpoints
Bristol-Myers Squibb
Opdivo
Yervoy
small cell lung cancer
Flag link:
The top 15 pharma companies by 2018 revenue
The top 15 pharma companies by 2018 revenue
Fierce Pharma
JNJ
Roche
Pfizer
Novartis
Merck
GSK
Sanofi
AbbVie
Bayer
Eli Lilly
Amgen
Bristol-Myers Squibb
Gilead Sciences
Teva Pharmaceutical
AstraZeneca
Flag link:
Big Pharma come together for better drug side effect detection
Big Pharma come together for better drug side effect detection
Pharma Times
side effects
adverse events
Pfizer
Roche
Takeda
Eli Lilly
Bristol-Myers Squibb
Gilead Sciences
Alexion
Celgene
International Working Group on Signal Detection and Management in Pharmacovigilance
pharmacovigilance
Flag link:
Bristol-Myers' big Celgene buyout showers $187M-plus on Morgan Stanley
Bristol-Myers' big Celgene buyout showers $187M-plus on Morgan Stanley
Endpoints
Bristol-Myers Squibb
Celgene
Morgan Stanley
M&A
Flag link:
Despite research boom, few immunotherapy studies targeting pancreatic cancer
Despite research boom, few immunotherapy studies targeting pancreatic cancer
Biopharma Dive
pancreatic cancer
cancer immunotherapy
AACR
Bristol-Myers Squibb
Merck
Apexigen
Flag link:
Bristol-Myers Squibb's Opdivo-Yervoy duo provokes response in rare tumors
Bristol-Myers Squibb's Opdivo-Yervoy duo provokes response in rare tumors
Fierce Pharma
Bristol-Myers Squibb
Opdivo
Yervoy
neuroendocrine tumors
Flag link:

Pages